Initial medwatch submitted to the fda on 22/oct/2021.A review of the device labeling notes the following: the current overstitch¿ endoscopic suturing system (ess) instructions for use (ifu) addressed the known and potential event of "overstitch-clinical outcome device related" as follows: possible complications that may result from using the endoscopic suturing system include, but may not be limited to: nausea and / or vomiting, abdominal pain and / or bloating.Additional information: the device has not been returned for analysis.The investigator is waiting until the lot number of the device is known to determine whether a device history record (dhr) review is or is not required for this complaint.
|